Cardio3 BioSciences Has Been Selected to Present C3BS-CQR-1 Trial Data in Late Breaking Clinical Trial Session at European Society of Cardiology 2012 Heart Failure Congress

Cardio3 BioSciences Has Been Selected to Present C3BS-CQR-1 Trial Data in Late Breaking Clinical Trial Session at European Society of Cardiology 2012 Heart Failure Congress

Cardio3 BioSciences Announces CE Marking for its C-Cath® Injection Catheter

Cardio3 BioSciences Announces CE Marking for its C-Cath® Injection Catheter

Cardio3 BioSciences Granted GMP Certification

Cardio3 BioSciences Granted GMP Certification

Cardio3 BioSciences Receives ISO-13485 Certification

Cardio3 BioSciences Receives ISO-13485 Certification